| __timestamp | Opthea Limited | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 24518692 |
| Thursday, January 1, 2015 | 2361587 | 19886580 |
| Friday, January 1, 2016 | 4472869 | 12631689 |
| Sunday, January 1, 2017 | 5030957 | 21977998 |
| Monday, January 1, 2018 | 4988941 | 20759000 |
| Tuesday, January 1, 2019 | 5196412 | 20838000 |
| Wednesday, January 1, 2020 | 6652774 | 121812000 |
| Friday, January 1, 2021 | 18418247 | 152137000 |
| Saturday, January 1, 2022 | 24827066 | 83231000 |
| Sunday, January 1, 2023 | 41896408 | 122706000 |
| Monday, January 1, 2024 | 15488619 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding financial trends is crucial for investors and stakeholders. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and TG Therapeutics, Inc. from 2014 to 2023. Over this period, TG Therapeutics, Inc. consistently outpaced Opthea Limited in SG&A spending, peaking in 2021 with expenses nearly 6 times higher than Opthea's. Notably, TG Therapeutics saw a dramatic increase in 2020, with expenses surging by over 500% compared to 2019. Meanwhile, Opthea's SG&A expenses showed a steady upward trend, culminating in a significant spike in 2023, marking a 170% increase from the previous year. These trends highlight the aggressive expansion strategies of both companies, with TG Therapeutics leading the charge. Missing data for 2024 suggests a need for cautious interpretation of future projections.
Selling, General, and Administrative Costs: Johnson & Johnson vs Opthea Limited
Breaking Down SG&A Expenses: Amgen Inc. vs Opthea Limited
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Opthea Limited
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and TG Therapeutics, Inc.
Comparing SG&A Expenses: Ascendis Pharma A/S vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Opthea Limited
Halozyme Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Pharming Group N.V. vs TG Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Amicus Therapeutics, Inc.
Opthea Limited or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
TG Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends